Incyte Corporation

Incyte Corporation is a biopharmaceutical company that focuses on developing innovative drugs, primarily for cancer and other serious diseases. Founded in 1991 and based in Delaware, Incyte is known for its research in targeted therapies, which aim to attack specific cancer cells while minimizing damage to healthy tissue. Their most notable product is Jakafi, used to treat certain blood disorders. Incyte collaborates with other companies and researchers to advance its pipeline of potential treatments, contributing to the evolving field of precision medicine. Their mission is to improve patient outcomes through cutting-edge science and effective therapies.